Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04657991
Title A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Pfizer

skin melanoma



Binimetinib + Encorafenib + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA | ITA | ESP | DEU | CAN | BEL

Additional content available in CKB BOOST